Suppr超能文献

[足部术中组织样本的组织病理学夏科氏评分:一项前瞻性研究]

[Histopathological Charcot score on intraoperative tissue samples from the foot : A prospective investigation].

作者信息

Illgner Ulrich, Mehlhorn Alexander T, Osada Nani, Krenn Veit

机构信息

Technische Orthopädie am Zentrum für Gefäß- und Wundmedizin, Gemeinschaftsklinikum Mittelrhein, Bahnhofstraße 7, 56154, Boppard, Deutschland.

Sektion für Diabetische und Neuropathische Fußerkrankungen, Zentrum für Fuß- und Sprunggelenkschirurgie, Schönklinik München-Harlaching, München-Harlaching, Deutschland.

出版信息

Orthopade. 2019 Aug;48(8):693-703. doi: 10.1007/s00132-019-03769-8.

Abstract

BACKGROUND

Charcot neuropathy is a severe complication in patients with neuropathy. Without treatment, CN can lead to a destruction and collapse of the foot, with subsequent ulceration and infection. Finding an early diagnosis is essential and is based on clinical and radiological parameters (X-ray and MRI) because there is still no specific and reliable test.

GOAL

Defining and validation of a Charcot score with defined histopathologic criteria.

METHOD

Tissue samples from 37 surgeries (Charcot-group n = 20, control-group n = 17) from tarsal bones were taken prospectively. A semiquantitative histopathological score based on four defined criteria of fibrous-osteo-cartilage tissues (maximum 21 points) was defined, the scoring modalities were orientated towards the evaluated HOES score (histopathological osteomyelitis evaluation score) for osteomyelitis. A comparison of the Charcot-group with diabetes mellitus and verified CN as well as neuropathy with the control group with signs of CN or neuropathy was performed.

RESULTS

Significant differences could be shown between the Charcot group and the control group in the score (10.5 vs 3.5 pts, p-value <0.001). There was a high significant correlation between the established tools for diagnostics of CN and the score (p-value <0,001).

CONCLUSION

The histopathological Charcot score can detect a CN with high significance and correlates with high significance to established diagnostic tools for CN. It could represent a simple and cost-effective additive tool to verify CN in uncertain cases.

摘要

背景

夏科氏神经病变是神经病变患者的一种严重并发症。未经治疗,夏科氏神经病变可导致足部破坏和塌陷,继而发生溃疡和感染。由于目前仍没有特异性和可靠的检测方法,早期诊断至关重要,且基于临床和放射学参数(X线和磁共振成像)。

目的

定义并验证具有明确组织病理学标准的夏科氏评分。

方法

前瞻性地采集了来自跗骨的37例手术组织样本(夏科氏组n = 20,对照组n = 17)。基于纤维-骨-软骨组织的四个明确标准定义了一个半定量组织病理学评分(最高21分),评分方式以评估骨髓炎的HOES评分(组织病理学骨髓炎评估评分)为导向。对患有糖尿病且确诊为夏科氏神经病变的夏科氏组与有夏科氏神经病变或神经病变体征的对照组进行了比较。

结果

夏科氏组与对照组在评分上存在显著差异(10.5分对3.5分,p值<0.001)。已有的夏科氏神经病变诊断工具与该评分之间存在高度显著相关性(p值<0.001)。

结论

组织病理学夏科氏评分能够高度显著地检测出夏科氏神经病变,且与已有的夏科氏神经病变诊断工具高度相关。它可能是一种简单且经济高效的辅助工具,用于在不确定的病例中验证夏科氏神经病变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验